Specific regional differences of in vitro β-endorphin metabolism in schizophrenics

Thomas P Davis, Alison J. Culling-Berglund, Hans Schoemaker

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Incubation of β-endorphin (β-E; 25μM) with twice-washed brain membrane homogenates leads to the formation of several biologically active peptide fragments which have been shown to be present in the brain. Based on clinical studies, some of these endorphin fragments have been shown to be active in patients with neuropsychiatric disease states. We studied the regional specificity of β-E metabolism in frontal cortex versus putamen from sex and age matched controls versus subjects with a diagnosis of schizophrenia. The present study demonstrates that cortical tissue has a lower rate of γ-endorphin production from β-E and a similar rate of des-tyrosine-γ-endorphin production. Significant differences were noted in the production of other active fragments (β-E (1-16, 2-16, 6-21)). These results support the hypothesis that there is a regional specificity of β-E metabolism in the brain, and these differences may have important functional consequences to secreted peptides and important clinical consequences in schizophrenia.

Original languageEnglish (US)
Pages (from-to)2601-2609
Number of pages9
JournalLife Sciences
Volume39
Issue number26
DOIs
StatePublished - Dec 29 1986

Fingerprint

Endorphins
Metabolism
Brain
Schizophrenia
Peptide Fragments
Putamen
Frontal Lobe
Tyrosine
Tissue
Membranes
Peptides
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology

Cite this

Specific regional differences of in vitro β-endorphin metabolism in schizophrenics. / Davis, Thomas P; Culling-Berglund, Alison J.; Schoemaker, Hans.

In: Life Sciences, Vol. 39, No. 26, 29.12.1986, p. 2601-2609.

Research output: Contribution to journalArticle

Davis, Thomas P ; Culling-Berglund, Alison J. ; Schoemaker, Hans. / Specific regional differences of in vitro β-endorphin metabolism in schizophrenics. In: Life Sciences. 1986 ; Vol. 39, No. 26. pp. 2601-2609.
@article{3e17f7e06da643728a5e4d94b2a02bd8,
title = "Specific regional differences of in vitro β-endorphin metabolism in schizophrenics",
abstract = "Incubation of β-endorphin (β-E; 25μM) with twice-washed brain membrane homogenates leads to the formation of several biologically active peptide fragments which have been shown to be present in the brain. Based on clinical studies, some of these endorphin fragments have been shown to be active in patients with neuropsychiatric disease states. We studied the regional specificity of β-E metabolism in frontal cortex versus putamen from sex and age matched controls versus subjects with a diagnosis of schizophrenia. The present study demonstrates that cortical tissue has a lower rate of γ-endorphin production from β-E and a similar rate of des-tyrosine-γ-endorphin production. Significant differences were noted in the production of other active fragments (β-E (1-16, 2-16, 6-21)). These results support the hypothesis that there is a regional specificity of β-E metabolism in the brain, and these differences may have important functional consequences to secreted peptides and important clinical consequences in schizophrenia.",
author = "Davis, {Thomas P} and Culling-Berglund, {Alison J.} and Hans Schoemaker",
year = "1986",
month = "12",
day = "29",
doi = "10.1016/0024-3205(86)90115-3",
language = "English (US)",
volume = "39",
pages = "2601--2609",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "26",

}

TY - JOUR

T1 - Specific regional differences of in vitro β-endorphin metabolism in schizophrenics

AU - Davis, Thomas P

AU - Culling-Berglund, Alison J.

AU - Schoemaker, Hans

PY - 1986/12/29

Y1 - 1986/12/29

N2 - Incubation of β-endorphin (β-E; 25μM) with twice-washed brain membrane homogenates leads to the formation of several biologically active peptide fragments which have been shown to be present in the brain. Based on clinical studies, some of these endorphin fragments have been shown to be active in patients with neuropsychiatric disease states. We studied the regional specificity of β-E metabolism in frontal cortex versus putamen from sex and age matched controls versus subjects with a diagnosis of schizophrenia. The present study demonstrates that cortical tissue has a lower rate of γ-endorphin production from β-E and a similar rate of des-tyrosine-γ-endorphin production. Significant differences were noted in the production of other active fragments (β-E (1-16, 2-16, 6-21)). These results support the hypothesis that there is a regional specificity of β-E metabolism in the brain, and these differences may have important functional consequences to secreted peptides and important clinical consequences in schizophrenia.

AB - Incubation of β-endorphin (β-E; 25μM) with twice-washed brain membrane homogenates leads to the formation of several biologically active peptide fragments which have been shown to be present in the brain. Based on clinical studies, some of these endorphin fragments have been shown to be active in patients with neuropsychiatric disease states. We studied the regional specificity of β-E metabolism in frontal cortex versus putamen from sex and age matched controls versus subjects with a diagnosis of schizophrenia. The present study demonstrates that cortical tissue has a lower rate of γ-endorphin production from β-E and a similar rate of des-tyrosine-γ-endorphin production. Significant differences were noted in the production of other active fragments (β-E (1-16, 2-16, 6-21)). These results support the hypothesis that there is a regional specificity of β-E metabolism in the brain, and these differences may have important functional consequences to secreted peptides and important clinical consequences in schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0022973008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022973008&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(86)90115-3

DO - 10.1016/0024-3205(86)90115-3

M3 - Article

C2 - 2948088

AN - SCOPUS:0022973008

VL - 39

SP - 2601

EP - 2609

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 26

ER -